Skip to content

Oxygen Titration Protocol for Exertion of COPD Patients by an Automated Adjustment Device

Oxygen Titration Protocol for Exertion of COPD Patients by an Automated Adjustment Device: a Monocentric, Prospective, Cross-over Study.

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04189991
Enrollment
25
Registered
2019-12-09
Start date
2020-02-06
Completion date
2023-12-31
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Respiratory Insufficiency, COPD

Keywords

COPD, Long-term oxygen therapy, Six minutes walk test, Exertion, Rehabilitation

Brief summary

The aim of our study is to assess if an automated titration of oxygen flow during exertion can be a useful tool to determinate the level of oxygen required by COPD patients that are using oxygen therapy during exercise.

Detailed description

All patients referred to our centre of oxygen titration during exertion will be offered to participate in our study. After baseline assessments, patients will have an oxygen titration using two different methods in random order: * Usual titration protocol will include an manual oxygen increase during a titration 6 minutes walk test * Automatic titration protocol that will use the automated oxygen titration device to adjust oxygen flow rate during a titration 6 minutes walk test. After each titration protocol, the efficacy of the titration will be assessed in 3 validation 6 minutes walk tests during which oxygen flow will be set at: * The manually determined flow rate * The 95th percentile flow rate of the automatic titration * The median flow rate of the automatic titration During validation 6 minutes walk test, oxygen saturation, dyspnea, walked distance and heart rate will be recorded.

Interventions

DEVICEFree 02

With the manual oxygen titration, the physiotherapist adjust manually the oxygen flow using the FreeO2 device during a titration 6 minutes walk test. With the automated adjustment oxygen titration, the flow will be self adjusted by the FreeO2 device during a titration 6 minutes walk test. In that hase, the median flow rate and the 95th flow rate will be evaluated during the validation 6 minutes walk test.

Sponsors

ADIR Association
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

The same device will be used for both oxygen titration protocol and during 6 minutes walk tests.

Intervention model description

Patients will undergo titration 6 minutes walk test using the standard and the automatic method in random order.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 to 85 years * COPD patients at the stage of CRF under LTOT or desaturating at exercise * Written and signed consent

Exclusion criteria

* Patients under guardianship or curatorship. * Pregnant women * Patients with non-weaned smoking. * Patients using technical assistance to move * Inability to perform 6MWT due to locomotor disorders. * Inability to understand 6MWT due to cognitive disorders * Patients exacerbating * Unstable angora * myocardial infarction \< 1 month * HR at rest \> 120 bpm * systolic blood pressure \> 18 and/or diastolic blood pressure \> 10

Design outcomes

Primary

MeasureTime frameDescription
Time spent in the pulse oxygen saturation target (Sp02) which is 92% +/- 2 during validation 6 minutes walk-test6 minutesThe time spent will be retrieved from the oxygen delivery device. it will be expressed in percentage of time of the 6 minutes walk tests and seconds.

Secondary

MeasureTime frameDescription
Time spent with moderate hypoxemia (Sp02 <90%), severe hypoxemia (Sp02 <85%) or hyperoxia (Sp02> 94%).6 minutesThe time spent will be retrieved from the oxygen delivery device. it will be expressed in percentage of time of the 6 minutes walk tests and seconds.

Other

MeasureTime frameDescription
DyspnoeaBefore, after the 6MWT, 1 minute after the end of the 6MWT, 3 minutes, 6 minutes, 10 minutes.The dyspnea will be assessed using a BORG scale (0: Rest to 10: Maximal)
Tiredness of the lower limbsBefore, after the 6MWT, 1 minute after the end of the 6MWT, 3 minutes, 6 minutes, 10 minutes.Tiredness of the lower limbs will be assessed using a visual analogue scale (0: No tiredness at all to 10: Maximal tiredness)
Oxygen saturationBefore, after the 6MWT, 1 minute after the end of the 6MWT, 3 minutes, 6 minutes, 10 minutes.The oxygen saturation will be retrieved from the oxygen delivery device. it will be expressed in percentage of time of the 6 minutes walk tests and seconds.
Time spent to perform the titrations30 minutesThe time spent for each titration procedure will be assessed using a chronometer.
Distance walked during the validation 6 minutes walk test6 minutesTHe distance will be measured using a metered corridor with a meter precision
Heart rateBefore, after the 6MWT, 1 minute after the end of the 6MWT, 3 minutes, 6 minutes, 10 minutes.The heart rate will be retrieved from the oxygen delivery device. it will be expressed in percentage of time of the 6 minutes walk tests and seconds.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026